Хайлтын үр дүнгүүд - Srinivasaraghavan Kannan
- 19-н 1 - 19 үр дүнгүүдийг харуулж байна
-
1
-
2
-
3
-
4
Preclinical Characteristics of the Irreversible Pan-HER Kinase Inhibitor Neratinib Compared with Lapatinib: Implications for the Treatment of HER2-Positive and HER2-Mutated Breast... -н Denis M. Collins, Neil T. Conlon, Srinivasaraghavan Kannan, Chandra Verma, Lisa D. Eli, Alshad S. Lalani, John Crown
Хэвлэсэн 2019Revisão -
5
Discovery of novel interacting partners of PSMD9, a proteasomal chaperone: Role of an Atypical and versatile PDZ-domain motif interaction and identification of putative functional... -н Sangith, Nikhil, Srinivasaraghavan, Kannan, Sahu, Indrajit, Desai, Ankita, Medipally, Spandana, Somavarappu, Arun Kumar, Verma, Chandra, Venkatraman, Prasanna
Хэвлэсэн 2014текст -
6
Corrigendum to “Discovery of novel interacting partners of PSMD9, a proteasomal chaperone: Role of an Atypical and versatile PDZ-domain motif interaction and identification of puta... -н Sangith, Nikhil, Srinivasaraghavan, Kannan, Sahu, Indrajit, Desai, Ankita, Medipally, Spandana, Somavarappu, Arun Kumar, Verma, Chandra, Venkatraman, Prasanna
Хэвлэсэн 2015текст -
7
Molecular basis for dengue virus broad cross-neutralization by humanized monoclonal antibody 513 -н Wong, Yee Hwa, Kumar, Akshita, Liew, Chong Wai, Tharakaraman, Kannan, Srinivasaraghavan, Kannan, Sasisekharan, Ram, Verma, Chandra, Lescar, Julien
Хэвлэсэн 2018текст -
8
-
9
A Novel Class of Schistosoma mansoni Histone Deacetylase 8 (HDAC8) Inhibitors Identified by Structure-Based Virtual Screening and In Vitro Testing -н Conrad V. Simoben, Dina Robaa, Alokta Chakrabarti, Matthias Schmidt, Martin Marek, Julien Lancelot, Srinivasaraghavan Kannan, Jelena Melesina, T.B. Shaik, Raymond J. Pierce, Christophe Romier, Manfred Jung, Wolfgang Sippl
Хэвлэсэн 2018Artigo -
10
PDK1-SGK1 Signaling Sustains AKT-Independent mTORC1 Activation and Confers Resistance to PI3Kα Inhibition -н Pau Castel, Haley Ellis, Ružica Bago, Eneda Toska, Pedram Razavi, F. Javier Carmona, Srinivasaraghavan Kannan, Chandra Verma, Maura N. Dickler, Sarat Chandarlapaty, Edi Brogi, Dario R. Alessi, José Baselga, Maurizio Scaltriti
Хэвлэсэн 2016Artigo -
11
Structural Basis for the Inhibition of Histone Deacetylase 8 (HDAC8), a Key Epigenetic Player in the Blood Fluke Schistosoma mansoni -н Martin Marek, Srinivasaraghavan Kannan, Alexander‐Thomas Hauser, Marina de Moraes Mourão, Stéphanie Caby, Vincent Cura, Diana A. Stolfa, Matthias Schmidt, Julien Lancelot, Luiza F Andrade, Jean‐Paul Renaud, Guilherme Oliveira, Wolfgang Sippl, Manfred Jung, J. Cavarelli, Raymond J. Pierce, Christophe Romier
Хэвлэсэн 2013Artigo -
12
PARP4 interacts with hnRNPM to regulate splicing during lung cancer progression -н Yi Fei Lee, Cheryl Zi Jin Phua, Ju Yuan, Bin Zhang, May Yin Lee, Srinivasaraghavan Kannan, Yui Hei Jasper Chiu, Casslynn W.Q. Koh, Choon Kong Yap, Edwin Kok Hao Lim, Jianbin Chen, Y. Lim, Jane Jia Hui Lee, Anders J. Skanderup, Zhenxun Wang, Weiwei Zhai, Nguan Soon Tan, Chandra S. Verma, Yvonne Tay, Daniel S.W. Tan, Wai Leong Tam
Хэвлэсэн 2024Artigo -
13
Responsiveness of different MET tumour alterations to type I and type II MET inhibitors -н Yonina R. Murciano‐Goroff, Valentina Foglizzo, Jason Chang, Natasha Rekhtman, Ann Elizabeth Sisk, Jamie Gibson, Lia Judka, Karen R. Clemens, Paola Roa, Shaza Ahmed, Nicole Virginia Bremer, Courtney Lynn Binaco, Sherifah Kemigisha Muzungu, Estelamari Rodríguez, Madeline Merrill, Erica Sgroe, Matteo Repetto, Zsofia K. Stadler, Michael F. Berger, Helena A. Yu, Eneda Toska, Srinivasaraghavan Kannan, Chandra Verma, Alexander Drilon, Emiliano Cocco
Хэвлэсэн 2025Artigo -
14
FOXA1 Mutations Reveal Distinct Chromatin Profiles and Influence Therapeutic Response in Breast Cancer -н Amaia Arruabarrena-Aristorena, Jesper L.V. Mååg, Srushti Kittane, Yanyan Cai, Wouter R. Karthaus, Erik Ladewig, Jane Park, Srinivasaraghavan Kannan, Lorenzo Ferrando, Emiliano Cocco, Sik Yin Ho, Daisylyn Senna Tan, Mirna Sallaku, Fan Wu, Barbara Acevedo, Pier Selenica, Dara S. Ross, Matthew D. Witkin, Charles L. Sawyers, Jorge S. Reis‐Filho, Chandra Verma, Ralf Jauch, Richard P. Koche, José Baselga, Pedram Razavi, Eneda Toska, Maurizio Scaltriti
Хэвлэсэн 2020Artigo -
15
Design-rules for stapled peptides with in vivo activity and their application to Mdm2/X antagonists -н Arun Chandramohan, Hubert Josien, Tsz Ying Yuen, Ruchia Duggal, Diana Spiegelberg, Lin Yan, Yu‐Chi Juang, Lan Ge, Pietro G. A. Aronica, Hung Yi Kristal Kaan, Yee Hwee Lim, Andrea Peier, Brad Sherborne, Jerome Hochman, Songnian Lin, Kaustav Biswas, Marika Nestor, Chandra Verma, David P. Lane, Tomi K. Sawyer, R. M. Garbaccio, Brian Henry, Srinivasaraghavan Kannan, Christopher J. Brown, Charles W. Johannes, Anthony W. Partridge
Хэвлэсэн 2024Artigo -
16
Macrocyclization of an all-<scp>d</scp> linear α-helical peptide imparts cellular permeability -н Srinivasaraghavan Kannan, Pietro G. A. Aronica, Simon Ng, Dawn Thean Gek Lian, Yuri Frosi, Sharon Chee, Shimin Jiang, Tsz Ying Yuen, Ahmad Sadruddin, Hung Yi Kristal Kaan, Arun Chandramohan, Jin Huei Wong, Yaw Sing Tan, Zi Wei Chang, Fernando J. Ferrer‐Gago, Prakash Arumugam, Yi Han, Shiying Chen, Laurent Rénia, Christopher J. Brown, Charles W. Johannes, Brian Henry, David P. Lane, Tomi K. Sawyer, Chandra Verma, Anthony W. Partridge
Хэвлэсэн 2020Artigo -
17
TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors -н Emiliano Cocco, Ji Eun Lee, Srinivasaraghavan Kannan, Alison M. Schram, Helen Won, Sophie Shifman, Amanda Kulick, Laura Baldino, Eneda Toska, Amaia Arruabarrena-Aristorena, Srushti Kittane, Fan Wu, Yanyan Cai, Sabrina Arena, Benedetta Mussolin, Ram Kannan, Neil Vasan, Alexander N. Gorelick, Michael F. Berger, Ofra Novoplansky, Sankar Jagadeeshan, Yi Liao, Uwe Rix, Sandra Misale, Barry S. Taylor, Alberto Bardelli, Jaclyn F. Hechtman, David M. Hyman, Moshe Elkabets, Elisa de Stanchina, Chandra Verma, Andrea Ventura, Alexander Drilon, Maurizio Scaltriti
Хэвлэсэн 2020Carta -
18
High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer -н Marta Palafox, Laia Monserrat, Meritxell Bellet, Guillermo Villacampa, Abel González-Pérez, Mafalda Oliveira, Fara Brasó‐Maristany, Nusaïbah Ibrahimi, Srinivasaraghavan Kannan, Leonardo Mina, María Teresa Herrera-Abreu, Andreu Òdena, Mònica Sánchez-Guixé, Marta Capelán, Analía Azaro, Alejandra Bruna, Olga Rodríguez, Marta Guzmán, Judit Grueso, Cristina Viaplana, Javier Hernández‐Losa, Faye Su, Kui Lin, Robert B. Clarke, Carlos Caldas, Joaquı́n Arribas, Stefan Michiels, Alicia García‐Sanz, Nicholas C. Turner, Aleix Prat, Paolo Nucíforo, R. Dienstmann, Chandra Verma, Núria López-Bigas, Maurizio Scaltriti, Mónica Arnedos, Cristina Saura, Violeta Serra
Хэвлэсэн 2021Pré-impressão -
19
High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer -н Marta Palafox, Laia Monserrat, Meritxell Bellet, Guillermo Villacampa, Abel González-Pérez, Mafalda Oliveira, Fara Brasó‐Maristany, Nusaïbah Ibrahimi, Srinivasaraghavan Kannan, Leonardo Mina, María Teresa Herrera-Abreu, Andreu Òdena, Mònica Sánchez-Guixé, Marta Capelán, Analía Azaro, Alejandra Bruna, Olga Rodríguez, Marta Guzmán, Judit Grueso, Cristina Viaplana, Javier Hernández‐Losa, Faye Su, Kui Lin, Robert B. Clarke, Carlos Caldas, Joaquı́n Arribas, Stefan Michiels, Alicia García‐Sanz, Nicholas C. Turner, Aleix Prat, Paolo Nucíforo, Rodrigo Dienstmann, Chandra Verma, Núria López-Bigas, Maurizio Scaltriti, Mónica Arnedos, Cristina Saura, Violeta Serra
Хэвлэсэн 2022Artigo
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Biology
Cancer research
Gene
Genetics
Biochemistry
Cancer
Chemistry
Cell biology
Medicine
Breast cancer
Computational biology
Internal medicine
Mutant
Oncology
Receptor
Biophysics
Estrogen receptor
Kinase
Mutation
Acquired resistance
Bioinformatics
Computational chemistry
DNA
Druggability
Estrogen receptor alpha
Gene expression
HDAC8
Helminths
Histone
Histone deacetylase